Business Context and Reporting Period
DNA X, Inc. (formerly Sonim Technologies, Inc.) filed this Form 8-K on February 9, 2026. The filing reports significant changes in executive leadership and compensatory arrangements effective as of the report date.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and executive compensation adjustments.
Material Changes
- Leadership Change: Mike Mulica, previously Executive Chairman, was appointed Acting Chief Executive Officer (CEO) and designated as the Principal Executive Officer effective February 9, 2026.
- CEO Compensation: Mr. Mulica's annual base salary was increased to $450,000 (effective January 30, 2026). He was granted 50,000 Restricted Stock Units (RSUs) vesting monthly over one year. The agreement includes COBRA premium reimbursement for up to 12 months upon termination.
- CFO Compensation: Clay Crolius, Chief Financial Officer, entered into a second amendment to his employment agreement. This amendment recognizes the completion of an asset sale on January 23, 2026, as a triggering event. He received a grant of 35,000 RSUs vesting monthly over one year and is eligible for COBRA reimbursement for up to 6 months upon termination.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, financial outlook, or specific risk factors. It notes that the asset sale completed on January 23, 2026, triggered specific provisions in the CFO's employment agreement. The text references the full employment amendments (Exhibits 10.1 and 10.2) for complete terms regarding early-termination conditions.
Investor Verification Checklist
- Verify the terms of the asset sale completed on January 23, 2026, and its impact on the company's remaining operations.
- Review the full text of the CEO and CFO employment amendments (Exhibits 10.1 and 10.2) for specific termination clauses and vesting acceleration conditions.
- Confirm the status of the search for a permanent CEO, as Mr. Mulica's appointment is currently "Acting."
- Check subsequent filings for the impact of the leadership transition on the company's strategic direction.